Table 1.
Clinical and ultrasound evaluation in S. mansoni and HTLV-1 Co-infected patients and patients only infected by S. mansoni
| Schistosomiasis groups | |||
|---|---|---|---|
| Patient characteristics | HTLV-1 coinfected (n = 22) | HTLV-1-noninfected (n = 44) | P-value |
| Age (mean ± SD) | 40 ± 10 | 32 ± 12 | >0·05 |
| Gender (male/female) | 13/9 | 26/18 | >0·05 |
| Hepatomegaly | 1/22 (4·5%) | 11/44 (25%) | = 0·05 |
| Splenomegaly | 0/22 (0%) | 2/44 (4·5%) | >0·05 |
| Ultrasound degree I | 21/22 (95·5%) | 29/44 (66%) | <0·05 |
| Ultrasound degree II | 1/22 (4·5%) | 15/44 (34%) | <0·05 |
| Kato Katz (X) | 24 eggs/g stool gram | 399 eggs/g stool | <0·05 |
Grade III fibrosis was not observed. In this study only 8 of 66 patients evaluated had other parasites (S. stercoralis, A. lumbricoides and T. trichiura) that was distributed in each group. These patients were treated for other helminthes prior to the immunological evaluation.